Growth Metrics

Merck (MRK) Current Taxes (2016 - 2026)

Merck has reported Current Taxes over the past 18 years, most recently at $3.9 billion for Q1 2026.

  • Quarterly Current Taxes fell 23.84% to $3.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.9 billion through Mar 2026, down 23.84% year-over-year, with the annual reading at $4.7 billion for FY2025, 20.75% up from the prior year.
  • Current Taxes was $3.9 billion for Q1 2026 at Merck, down from $4.7 billion in the prior quarter.
  • Over five years, Current Taxes peaked at $5.2 billion in Q1 2025 and troughed at $1.4 billion in Q2 2022.
  • The 5-year median for Current Taxes is $2.6 billion (2023), against an average of $3.0 billion.
  • Year-over-year, Current Taxes skyrocketed 118.58% in 2024 and then fell 23.84% in 2026.
  • A 5-year view of Current Taxes shows it stood at $2.0 billion in 2022, then skyrocketed by 33.38% to $2.6 billion in 2023, then surged by 47.75% to $3.9 billion in 2024, then grew by 20.75% to $4.7 billion in 2025, then fell by 16.5% to $3.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Current Taxes are $3.9 billion (Q1 2026), $4.7 billion (Q4 2025), and $4.8 billion (Q3 2025).